CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Baxter forecasts 2%-3% organic sales growth and $1.95-$2.15 EPS for 2026 as tariff refund lifts Q2 results

EarningsPositive
AI Analysis

Summary

Baxter International issued 2026 guidance forecasting 2%-3% organic sales growth and EPS of $1.95-$2.15, with Q2 results supported by a tariff refund.

Financial Highlights

EPS

$1.95-$2.15

Guidance

2%-3% organic sales growth for 2026

Importance:4/10
Sentiment:
0.30
guidanceearningstariff_refundQ2_results
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 30, 2026 4:25 PM

Read Original